Navigation
Market Outlook Stock Screener Dividend Calendar Event Calendar Rating of shares Markets News
Try free

Ironwood Pharmaceuticals

NASDAQ IRWD
$7.00 0.26 3.71%
Today share price
USA
Sector: Healthcare Industry: Biotechnology
Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Rating Finrange

Index: 18 %
Market cap

Market capitalization – refers to the total value of all a company's shares of stock. It is calculated by multiplying the price of a stock by its total number of outstanding shares.

1.10B
EV

Enterprise value is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. Enterprise value includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.
1.71B
Beta

Beta is one of the most popular indicators of risk is a statistical measure. Analysts use this measure often when they need to determine a stock's risk profile.
1.31
Shares

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company’s insiders.
157.70M
YTD

Year to date (YTD) refers to the period of time beginning the first day of the current calendar year or fiscal year up to the current date. he acronym often modifies concepts such as investment returns and price change.
-38.81 %

Upcoming events Ironwood Pharmaceuticals

All events
No upcoming events scheduled

Overview

Financials

Key Metrics

Dividends

Industry overview

Events

Stock chart Ironwood Pharmaceuticals

Stock analysis Ironwood Pharmaceuticals

Indicator Company Industry
P/E (LTM)

Shows how many years the investor's investment in the company will pay off with a profit over the last 12 months.

More
-1.07 27.46
P/BV (LTM)

Shows the ratio of the market price of the share to the current book value.

More
-3.19 4.32
EV/EBITDA (LTM)

Represents the ratio of the company's value to its pre-tax EBITDA in the last 12 months.

More
-1.74 9.63
Net Debt/EBITDA (LTM)

A company's debt ratio, which indicates how long the company will need to run on cash flow in the past 12 months to pay off its own debt.

More
-0.62 0.64
ROE (LTM)

Shows the efficiency of using the share capital by the company. In other words, ROE shows how much of the company's net profit for the invested capital over the last 12 months.

More
457.66 7.67

Price change Ironwood Pharmaceuticals per year

8.78$ 14.27$
Min Max

Summary analysis Ironwood Pharmaceuticals

Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Shareholder structure Ironwood Pharmaceuticals

Revenue and net income Ironwood Pharmaceuticals

All parameters

Stock news Ironwood Pharmaceuticals

All news
12 June 2023 в 23:30

Ironwood Pharmaceuticals' Pediatric Constipation Treatment Gets FDA Approval

12 June 2023 в 23:30

Ironwood Pharmaceuticals' Pediatric Constipation Treatment Gets FDA Approval

22 May 2023 в 15:45

Ironwood Pharmaceuticals to Buy VectivBio in $1 Billion Deal. The Sector Is Hot for M&A.

22 May 2023 в 15:45

Ironwood Pharmaceuticals to Buy VectivBio in $1 Billion Deal. The Sector Is Hot for M&A.

22 May 2023 в 14:55

Ironwood Pharmaceuticals to Acquire VectivBio for About $1 Billion

22 May 2023 в 14:50

Ironwood Pharmaceuticals to Acquire VectivBio for About $1 Billion

22 May 2023 в 14:15

Ironwood Pharmaceuticals to acquire Swiss biotech VectivBio in deal valued at about $1 billion

22 May 2023 в 14:00

Ironwood Pharmaceuticals expects deal to boost EPS by 2026

11 April 2023 в 15:56

Ironwood Pharmaceuticals Eliminates Chief Operating Officer Post

11 April 2023 в 15:51

Ironwood Pharmaceuticals Eliminates Chief Operating Officer Post

1 December 2021 в 15:45

Ironwood Pharmaceuticals Names Sravan Emany CFO

1 December 2021 в 15:40

Ironwood Pharmaceuticals Names Sravan Emany CFO

About company Ironwood Pharmaceuticals

Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZESS name in the United States and Mexico, as well as under the CONSTELLA name in the Canada and European Union. The company is also developing IW-3300, a GC-C agonist, which is in pre-clinical development for the treatment of visceral pain conditions, including interstitial cystitis/bladder pain syndrome and endometriosis. It has strategic partnerships with AbbVie Inc., AstraZeneca AB, and Astellas Pharma Inc. for the development and commercialization of linaclotide. The company was formerly known as Microbia, Inc. and changed its name to Ironwood Pharmaceuticals, Inc. in April 2008. Ironwood Pharmaceuticals, Inc. was incorporated in 1998 and is headquartered in Boston, Massachusetts.
Address:
100 Summer Street, Boston, MA, United States, 02110
Company name: Ironwood Pharmaceuticals
Issuer ticker: IRWD
ISIN: US46333X1081
Country: USA
Exchange: NASDAQ
Currency: $
IPO date: 2010-02-03
Sector: Healthcare
Industry: Biotechnology
Site: https://www.ironwoodpharma.com

On which stock exchange are Ironwood Pharmaceuticals (IRWD) stocks traded?

Ironwood Pharmaceuticals (IRWD) stocks are traded on NASDAQ.

What is the ticker of Ironwood Pharmaceuticals stocks (IRWD)?

The stock ticker of Ironwood Pharmaceuticals’s stocks or in other words, the code is IRWD. The stocks are currently listed on the NASDAQ exchange.

In which sector and industry does Ironwood Pharmaceuticals (IRWD) operate?

According to the GICS (Global Industry Classification Standard) classification developed jointly by MSCI and Standard & Poor's, Ironwood Pharmaceuticals (IRWD) belongs to the «Healthcare» sector and the «Biotechnology» industry.

In what currency are Ironwood Pharmaceuticals (IRWD) stocks traded?

Ironwood Pharmaceuticals (IRWD) stocks are traded on the NASDAQ exchange in dollars.

What is the price of Ironwood Pharmaceuticals (IRWD) stocks today?

The current price of Ironwood Pharmaceuticals stocks on 14.05.2024 is 7 dollars. per share.

What is the dynamics of Ironwood Pharmaceuticals (IRWD) stocks from the beginning of the year?

Ironwood Pharmaceuticals (IRWD) quotes have increased by -43.59% from the beginning of the year up to 7 dollars. per 1 stocks.

How much did Ironwood Pharmaceuticals (IRWD) stocks increase in мае 2024?

This month Ironwood Pharmaceuticals (IRWD) quotes have increased by -14.84% to 7 dollars. per share.

How much are Ironwood Pharmaceuticals (IRWD) stocks worth?

Today, on October, 14.05.2024 Ironwood Pharmaceuticals’s (IRWD) stocks cost 7 dollars..

What is the market capitalization of Ironwood Pharmaceuticals (IRWD)?

Capitalization is the market value of Ironwood Pharmaceuticals (IRWD) is calculated as the number of issued stocks multiplied on the current quotation price. Thus, on 14.05.2024, the market capitalization of Ironwood Pharmaceuticals (IRWD) is estimated at about 1103900000 dollars.